Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Faster, slicker, customisable & ad free!Summer Special! Get NewsNow Essentials at just £1.99 a month (50% OFF!). Subscribe and saveSummer Special! Upgrade here at £1.99/m (50% OFF!)

Home
Hot Topics
Australia
World
Sport
Business
Entertainment
Science
Technology
Lifestyle

"Hanmi"
Topics

Advertisement

Advertisement

"Hanmi"

Showing articles that match "Hanmi" in the headline

In the last hour

Hanmi puts AI to work on 4,000 SOPs in quality assurance overhaul Korea Biomedical Review 08:28

Friday

Hanmi’s once-weekly hyperinsulinism drug advances in global phase 2 Korea Biomedical Review 06:27 Fri, 04 Sep

Thursday

Here's Why We Think Hanmi Pharm (KRX:128940) Is Well Worth Watching Simply Wall St 05:25 Thu, 03 Sep

Advertisement

Advertisement

In the last month

Hanmi Science taps Megazone to expand AI use across group Korea Biomedical Review 08:16 Tue, 01 Sep

Hanmi Pharm in spotlight as Korea's 1st obesity drug nears launch The Korea Times 07:15 Wed, 26 Aug

Genentech licenses Hanmi’s UCN2 obesity candidate in $2.3bn deal European Pharmaceutical Review 11:06 Tue, 25 Aug

Roche outlays $2.3bn for Hanmi’s non-GLP-1 obesity candidate Pharmaceutical Technology 23:40 Mon, 24 Aug

Hanmi that CV MoA: Roche lured to $2.3B metabolic pact BioWorld 21:41 Mon, 24 Aug

Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug... pharmaphorum 15:37 Mon, 24 Aug

Hanmi licenses UCN2 obesity drug candidate HM17321 to Genentech in $2.3bn deal Manufacturing Chemist 10:18 Mon, 24 Aug

Hanmi lands $2.3 billion obesity drug deal with Roche's Genentech Korea JoongAng Daily 09:37 Mon, 24 Aug

Hanmi Pharm signs 3.2 tln-won licensing deal with Roche's Genentech for obesity drug candidate Yonhap News Agency 09:02 Mon, 24 Aug

Hanmi Pharm shares surge 30% after $2.3 bil. Genentech obesity drug deal Korea Biomedical Review 07:58 Mon, 24 Aug

Hanmi Pharm signs $2.3 bil. licensing deal with Roche's Genentech for obesity drug candidate The Korea Times 07:22 Mon, 24 Aug

Hanmi signs record $2.3b obesity drug deal with Genentech The Korea Herald 06:31 Mon, 24 Aug

Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy PR Newswire (Press Release) 05:45 Mon, 24 Aug

Hanmi highlights clopidogrel's long-term edge over aspirin after PCI Korea Biomedical Review 03:32 Mon, 24 Aug

Hanmi Pharmaceutical ahead of launching anti-obesity drug EPPE Asia Today 02:49 Thu, 20 Aug

Advertisement

Hanmi Financial (HAFC) Could Be a Great Choice Zacks 17:47 Wed, 19 Aug

Advertisement

Advertisement

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Hot Topics Hot Topics
Australia Australia
World World
Sport Sport
Business Business
Entertainment
Science Science
Technology Technology
Lifestyle Lifestyle